SAKK Swiss Group for Clinical Cancer Research

The Swiss Group for Clinical Cancer Research (SAKK) has committed itself to conducting clinical cancer trials as a non-profit organization. It is our goal to investigate new cancer therapies and to improve existing tumor treatments, taking into account all available treatment options, in order to cure the disease or to prolong survival and improve life quality of patients suffering from cancer. Research is conducted through a national network and in cooperation with centers and study groups abroad

Klinische krebsforschung

Sakk swiss group for clinical cancer research operates in the Research industry.

Sakk swiss group for clinical cancer research's revenue is $55.50m

Sakk swiss group for clinical cancer research has 51 - 200 employees.